Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial

Study ID Citation

Guest EM, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz M, Loh ML, Hunger SP, Brown PA. Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial. Haematologica. 2022 May 1;107(5):1205-1208. doi: 10.3324/haematol.2021.280146. PubMed PMID: 35172563; PubMed Central PMCID: PMC9052896.

Abstract

No abstract provided.

Link To Publication opens in a new tab